• 1
    Larsson H, Carlsson E, Ryberg B, Fryklund J, Wallmark B. Rat parietal cell function after prolonged inhibition of gastric acid secretion. Am J Physiol 1988; 254: G339.
  • 2
    Waldum HL, Arnestad JS, Brenna E, Eide I, Syversen U, Sandvik AK. Marked increase in gastric acid secretory capacity after omeprazole treatment. Gut 1996; 39: 64953.
  • 3
    Gillen D, McColl KE. Problems related to acid rebound and tachyphylaxis. Baillieres Best Pract Res Clin Gastroenterol 2001; 15: 48795.
  • 4
    Gillen D, Wirz AA, Ardill JE, McColl KE. Rebound hypersecretion after omeprazole and its relation to on-treatment acid suppression and Helicobacter pylori status. Gastroenterology 1999; 116: 23947.
  • 5
    Gillen D, Wirz AA, McColl KE. Helicobacter pylori eradication releases prolonged increased acid secretion following omeprazole treatment. Gastroenterology 2004; 126: 9808.
  • 6
    Fullarton GM, McLauchlan G, Macdonald A, Crean GP, McColl KE. Rebound nocturnal hypersecretion after four weeks treatment with an H2 receptor antagonist. Gut 1989; 30: 44954.
  • 7
    Havu N. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 1986; 35 (Suppl. 1): 4255.
  • 8
    Sundler F, Hakanson R, Carlsson E, Larsson H, Mattsson H. Hypergastrinemia after blockade of acid secretion in the rat: trophic effects. Digestion 1986; 35 (Suppl. 1): 5669.
  • 9
    Brenna E, Waldum HL. Trophic effect of gastrin on the enterochromaffin like cells of the rat stomach: establishment of a dose response relationship. Gut 1992; 33: 13036.
  • 10
    Bakke I, Qvigstad G, Brenna E, Sandvik AK, Waldum HL. Gastrin has a specific proliferative effect on the rat enterochromaffin-like cell, but not on the parietal cell: a study by elutriation centrifugation. Acta Physiol Scand 2000; 169: 2937.
  • 11
    Tielemans Y, Axelson J, Sundler F, Willems G, Hakanson R. Serum gastrin concentration affects the self replication rate of the enterochromaffin like cells in the rat stomach. Gut 1990; 96: 2748.
  • 12
    Kleveland PM, Haugen SE, Waldum HL. The preparation of bioactive 125I-gastrin, using iodogen as oxidizing agent, and the use of this tracer in receptor studies. Scand J Gastroenterol 1985; 20: 56976.
  • 13
    Syversen U, Jacobsen MB, O'Connor DT, Ronning K, Waldum HL. Immunoassays for measurement of chromogranin A and pancreastatin-like immunoreactivity in humans: correspondence in patients with neuroendocrine neoplasia. Neuropeptides 1994; 26: 2016.
  • 14
    Norlén P, Vinge E. Proton pumps inhibitors can create chronic needs. Lakartidningen 2003; 100: 9401.
  • 15
    Melander A. Focus on proton pump inhibitors. The phenomenon of (over)compensation is not odd but normal. Lakartidningen 2003; 100: 923.
  • 16
    Qvigstad G, Waldum H. Rebound hypersecretion after inhibition of gastric acid secretion. Pharmacol Toxicol 2004; 94: 2028.
  • 17
    Ryberg B, Tielemans Y, Axelson J, et al. Gastrin stimulates the self-replication rate of enterochromaffin-like cells in the rat stomach. Effects of omeprazole, ranitidine, and gastrin-17 in intact and antrectomized rats. Gastroenterology 1990; 99: 93542.
  • 18
    Eissele R, Brunner G, Simon B, Solcia E, Arnold R. Gastric mucosa during treatment with lansoprazole: Helicobacter pylori is a risk factor for argyrophil cell hyperplasia. Gastroenterology 1997; 112: 70717.
  • 19
    Simonsson M, Eriksson S, Hakanson R, et al. Endocrine cells in the human oxyntic mucosa. A histochemical study. Scand J Gastroenterol 1988; 23: 108999.
  • 20
    Ronning K, Sandvik AK, Waldum HL. The fade of gastrin-stimulated gastric acid secretion in the rat is due to depletion of releasable mucosal histamine. Acta Physiol Scand 1996; 157: 48791.
  • 21
    Kleveland PM, Waldum HL, Larsson H. Gastric acid secretion in the totally isolated, vascularly perfused rat stomach. A selective muscarinic-1 agent does, whereas gastrin does not, augment maximal histamine-stimulated acid secretion. Scand J Gastroenterol 1987; 22: 70513.
  • 22
    Marks IN, Komarov SA, Shay H. Maximal acid secretory response to histamine and its relation to parietal cell mass in the dog. Am J Physiol 1960; 199: 57988.
  • 23
    Waldum HL, Brenna E, Sandvik AK. Maximal gastric acid secretion in man: a concept that needs precision. Scand J Gastroenterol 1998; 33: 100915.
  • 24
    Magami Y, Azuma T, Inokuchi H, Moriyasu F, Kawai K, Hattori T. Cell kinetics of slow renewing cell populations in mice stomach. J Gastroenterol Hepatol 2002; 17: 2629.
  • 25
    Tielemans Y, Willems G, Sundler F, Hakanson R. Self-replication of enterochromaffin-like cells in the mouse stomach. Digestion 1990; 45: 13846.
  • 26
    Lipkin M. Proliferation and differentiation of mucus containing cells in normal and diseased mucosa. Digestive mucus secretions. Biol Gastroenterol (Paris) 1972; 5: 500c.
  • 27
    Kleveland O, Syversen U, Slordahl K, Waldum HL. Hypergastrinemia as a cause of chromogranin a increase in blood in patients suspected to have neuroendocrine tumor. Digestion 2001; 64: 714.
  • 28
    Waldum HL, Syversen U. Serum chromogranin A in the control of patients on long-term treatment with inhibitors of acid secretion. Eur J Clin Invest 2001; 31: 7413.
  • 29
    Waldum HL, Syversen U. Chromogranin A (CgA) and the enterochromaffin-like (ECL) cell. In: Helle, KB, Aunis, D, eds. Chromogranins: Functional and Clinical Aspects. New York: Kluwer Academic/Plenum Publishers, 2000: 3617.
  • 30
    Sanduleanu S, De Bruine A, Stridsberg M, et al. Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy. Eur J Clin Invest 2001; 31: 80211.
  • 31
    Hakanson R, Ding XQ, Norlen P, Chen D. Circulating pancreastatin is a marker for the enterochromaffin-like cells of the rat stomach. Gastroenterology 1995; 108: 144552.
  • 32
    Frislid K, Aadland E, Berstad A. Augmented postprandial gastric acid secretion due to exposure to ranitidine in healthy subjects. Scand J Gastroenterol 1986; 21: 11922.
  • 33
    Nwokolo CU, Smith JT, Sawyerr AM, Pounder RE. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2 receptor blockade. Gut 1991; 32: 145560.
  • 34
    Qvigstad G, Arnestad JS, Brenna E, Waldum HL. Treatment with proton pump inhibitors induces tolerance to histamine-2 receptor antagonists in Helicobacter pylori-negative patients. Scand J Gastroenterol 1998; 33: 12448.
  • 35
    Bilchik AJ, Nilsson O, Modlin IM, Sussman J, Zucker KA, Adrian TE. H2-receptor blockade induces peptide YY and enteroglucagon-secreting gastric carcinoids in mastomys. Surgery 1989; 106: 111926 (see Discussion 10).
  • 36
    Ekman L, Hansson E, Havu N, Carlsson E, Lundberg C. Toxicological studies on omeprazole. Scand J Gastroenterol Suppl 1985; 108: 5369.